Inhibited peroxidase activity of peroxiredoxin 1 by palmitic acid exacerbates nonalcoholic steatohepatitis in male mice. [PDF]
Yin W +22 more
europepmc +1 more source
Metabolic Syndrome Nonalcoholic Steatohepatitis Male Mouse With Adeno-Associated Viral Renin as a Novel Model for Heart Failure With Preserved Ejection Fraction. [PDF]
Shi Y +12 more
europepmc +1 more source
THR-β Agonist for Nonalcoholic Steatohepatitis Treatment: Challenges of a Promising Drug. [PDF]
Xue F, Wei L.
europepmc +1 more source
[NLRP3 signaling pathway promotes hepatocyte pyroptosis in mice with nonalcoholic steatohepatitis in hypoxic environment]. [PDF]
Luo S +6 more
europepmc +1 more source
Surging Liver Transplantation for Nonalcoholic Steatohepatitis from 2000-2022: A National Database Study. [PDF]
Ajayi T +5 more
europepmc +1 more source
<i>Capparis spinosa</i> Attenuates Hepatic Inflammation and Fibrosis by Suppressing Inflammatory Cytokines in a Wistar Rat Model of Nonalcoholic Steatohepatitis. [PDF]
Akbari R +4 more
europepmc +1 more source
Related searches:
To determine the clinical relevance of nonalcoholic steatohepatitis (NASH) and to review the available literature on the epidemiology, clinical features, histology, pathogenesis, clinical course, and management of this condition.Pertinent articles in English identified through a MEDLINE search (1966 to the present) and the bibliographies of relevant ...
C A, Redlich, M R, Cullen
+9 more sources
Nonalcoholic steatohepatitis (NASH) has become a major cause of cirrhosis and liver-related deaths worldwide. NASH is strongly associated with obesity and the metabolic syndrome, conditions that cause lipid accumulation in hepatocytes (hepatic steatosis). It is not well understood why some, but not other, individuals with hepatic steatosis develop NASH.
Ayako, Suzuki, Anna Mae, Diehl
+5 more sources

